Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Other Non-Current Liabilities (2020 - 2021)

Historic Other Non-Current Liabilities for Protagonist Therapeutics (PTGX) over the last 2 years, with Q3 2021 value amounting to $121000.0.

  • Protagonist Therapeutics' Other Non-Current Liabilities fell 2882.35% to $121000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $121000.0, marking a year-over-year decrease of 2882.35%. This contributed to the annual value of $121000.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Protagonist Therapeutics reported Other Non-Current Liabilities of $121000.0 as of Q3 2021, which was down 2882.35% from $121000.0 recorded in Q2 2021.
  • Protagonist Therapeutics' Other Non-Current Liabilities' 5-year high stood at $170000.0 during Q3 2020, with a 5-year trough of $92000.0 in Q2 2020.